What You Should Know:
- Beta Boom, a pre-seed and seed-stage VC firm focused on impact investing, has secured $14.5 million for its Fund II.
- Led by Managing Partners Kimmy and Sergio Paluch, the fund targets early-stage startups addressing critical needs within fast-growing, underserved communities.
Investment Thesis & Focus
Beta Boom goes beyond traditional networks and tech hubs, looking for passionate founders with grit and deep understanding of the problems they solve. They
Read More
Digital Health | News, Analysis, Insights - HIT Consultant
ModMed Appoints Joe Harpaz as Co-CEO
What You Should Know:
- ModMed, practice technology leader and EHR pioneer, announcing the appointment of Joe Harpaz to co-CEO. Since 2018, Harpaz has served as President and Chief Operating Officer at ModMed responsible for helping the company execute against its revenue targets.
- As Co-CEO, Joe will continue to help shape the company’s vision and strategic direction, alongside ModMed co-founder and co-CEO Daniel Cane,
Read More
Sensos Nabs $20M for AI-Powered Supply Chain
What You Should Know:
Sensos a Sony Semiconductor Israel spin-off, has successfully closed its Series A funding round to further develop a proactive supply chain management solution. The funding was led by Mitsui-backed Magenta Venture Partners, who were joined by JAL Ventures, with the participation of Israel Cargo Logistics, and Sumitomo Corporation.The smart logistics industry that tracks shipments and manages remote inventory is fragmented, relying on partial digital solutions, poor
Read More
Samsung Galaxy Watch Receives FDA Nod for Sleep Apnea Detection
What You Should Know:
- Samsung's Galaxy Watch has received De Novo authorization from the US Food and Drug Administration (FDA) for its sleep apnea detection feature.
- This marks a significant step forward in wearable technology, making it the first of its kind to be approved by the FDA for detecting potential sleep apnea.
Defining Sleep Apnea
Sleep apnea is a common and chronic sleep disorder where breathing repeatedly stops and starts during sleep. This can lead to disruptions in
Read More
CareSource Becomes LP with Boomerang Ventures for Co-Investment Opportunities
What You Should Know:
- Boomerang Ventures, an early-stage venture studio and venture capital fund focused on connected health solutions, has announced a strategic partnership with CareSource, a nationally recognized non-profit managed care organization.
- The strategic collaboration marks a significant step towards advancing healthcare access, quality, and equity.
Partnership Benefits
CareSource becomes a Limited Partner: This investment empowers Boomerang to expand its reach
Read More
Medicare Expands Coverage for Eversense E3 CGM System, Offering More Options for Diabetes Management
What You Should Know:
- Medicare has significantly expanded access to the Eversense E3 continuous glucose monitoring (CGM) System, a long-lasting and implantable option that offers several advantages over traditional CGMs.
- Medicare has significantly expanded access to the Eversense E3 CGM System, the longest-lasting continuous glucose monitor available, with the implementation of Local Coverage Determinations providing access to implantable CGM for basal-only patients, by the first three
Read More
Ambient AI Scribes Reduce Clinician Burden, TPMG Pilot Reveals
What You Should Know:
- Ambient artificial intelligence (AI) scribes show early promise in reducing clinicians’ burden, according to a recent The Permanente Medical Group (TPMG) pilot.
- Published in NEJM Catalyst, TPMG recently implemented ambient AI scribes for 10,000 physicians and staff.
Ambient AI Scribes
Ambient AI scribes represent a cutting-edge technological solution designed to mitigate the documentation workload faced by physicians. By employing machine learning algorithms
Read More
Calibrate Appoints Rob MacNaughton as New CEO
What You Should Know:
- Calibrate, the leading clinician-guided and value-based obesity treatment program, today announced the appointment of Rob MacNaughton as its new Chief Executive Officer.
- Calibrate's strategic direction under MacNaughton's leadership and the OptumRx partnership position the company for significant growth and a positive impact on both individual and corporate healthcare landscapes.
MacNaughton Bio/Background
MacNaughton boasts a distinguished track record in
Read More
CentralReach Acquires Social-Emotional Learning Provider SILAS to Expand Education Suite
What You Should Know:
- CentralReach, a leading provider of Autism and Intellectual and Developmental Disabilities (IDD) software, announced the acquisition of SILAS, a company specializing in social and emotional learning (SEL) and behavior solutions for PreK-12 education.
- By combining SILAS's expertise in SEL and behavior with CentralReach's existing strengths in Autism and IDD support, the company is well-positioned to empower schools and educators in nurturing well-rounded and
Read More
Unlearn Raises $50M to Accelerate AI-Powered Clinical Trials with Digital Twins
What You Should Know:
- Unlearn®, a leading AI company using digital twins to revolutionize clinical trials, announced today a $50M Series C funding round led by Altimeter Capital. This investment, bringing Unlearn's total funding to over $130M, will fuel its mission to eliminate trial and error in medicine through faster, smaller, and more ethical clinical trials.
- Unlearn collaborates with pharmaceutical companies, biotechs, and academic institutions to optimize and streamline clinical
Read More
